ArticleAdvances in therapy2025

Comparing Real-World Outcomes of Prophylaxis with Extended Half-life Factor IX (rIX-FP vs. rFIXFc and N9-GP) for Haemophilia B: An Analysis of Medical Chart Data from Germany.

Martin Olivieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.